Mainīt reģionālos iestatījumus

| Renefort | Nephroprotective agent, reduces uric acid levels |
| Pielotax №60 | Prevents kidney damage from uric acid salts |
| Revilab ML 09 | Improves the condition of the joints, promotes their regeneration |
| Renefort | Nephroprotective agent, reduces uric acid levels |
| Sigumir №60 | Protect joints |
| Mesotel | Antioxidant, normalizes microcirculation |
| Chondromix | Chondroprotective and antioxidant |
| Ensil | Normalizes metabolic processes |
| Renefort | Nephroprotective agent, reduces uric acid levels |
| Sigumir №60 | Protect joints |
| Mesotel | Antioxidant, normalizes microcirculation |
| Chondromix | Chondroprotective and antioxidant |
| Ensil | Normalizes metabolic processes |
| Renefort | Nephroprotective agent, reduces uric acid levels |
| Pielotax №60 | Prevents kidney damage from uric acid salts |
| Revilab ML 09 | Improves the condition of the joints, promotes their regeneration |
| Renefort | Nephroprotective agent, reduces uric acid levels |
| Sigumir №60 | Protect joints |
| Mesotel | Antioxidant, normalizes microcirculation |
| Chondromix | Chondroprotective and antioxidant |
| Ensil | Normalizes metabolic processes |
| Renefort | Nephroprotective agent, reduces uric acid levels |
| Sigumir №60 | Protect joints |
| Mesotel | Antioxidant, normalizes microcirculation |
| Chondromix | Chondroprotective and antioxidant |
| Ensil | Normalizes metabolic processes |
| Regenart | Hepato- and chondroprotector |
| Nosaukums | Daudzums | Lietošanas norādījumi | Darbības mehānisms | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||